title: Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review.
abstract: The incidence of deep vein thrombosis (DVT) after non-myeloablative (NMA) allogeneic stem cell transplantation (allo-SCT) is unknown. In addition, very few studies on the predisposing factors for DVT post SCT have been published. The incidence of DVT among patients that underwent NMA allo-SCT at our hospital was 4.1% (3 of 73) over the course of last 8 years, and to the best of our knowledge this is the first study to report the incidence of DVT following NMA allo-SCT. The present findings show that NMA allo-SCT patients may have multiple risk factors for DVT. Herein we present 3 cases of DVT following NMA allo-SCT and a literature review.
  
  
  BACKGROUND
  None declared.
authors.affiliation: Hacettepe University, Institute of Oncology, Stem Cell Transplantation Unit, Ankara, Turkey.
authors.forename: Evren
authors.initials: E
authors.lastname: Ozdemir
authors.affiliation: Hacettepe University, Institute of Oncology, Stem Cell Transplantation Unit, Ankara, Turkey.
authors.forename: Emin
authors.initials: E
authors.lastname: Kansu
keywords: DVT; Non-myeloablative allogeneic stem cell transplantation; incidence